Pur-Wash
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
65785-168 -
Package NDC
65785-168-01 -
Package NDC
65785-168-02 -
Application number
NDA022305 -
SPL ID
445cc5f0-08a7-cb39-e063-6394a90abc68 -
SPL set ID
0d43b1c1-2699-37f1-e054-00144ff88e88 -
UNII
059QF0KO0R -
RxCUI
1151101 -
RxCUI
1424605
What the source publishes
- Labeler
- Niagara Pharmaceuticals, Inc.
- Active ingredients
- Eyewash
- Form
- SOLUTION
- Routes
- OPHTHALMIC
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN OTC DRUG
- Prescription
- Non-prescription
Names this record is found by
Complete source data
{
"name": "Pur-Wash",
"splId": "445cc5f0-08a7-cb39-e063-6394a90abc68",
"labels": [
{
"setId": "0d43b1c1-2699-37f1-e054-00144ff88e88",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0d43b1c1-2699-37f1-e054-00144ff88e88",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0d43b1c1-2699-37f1-e054-00144ff88e88"
}
],
"routes": [
"OPHTHALMIC"
],
"labeler": "Niagara Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "473 mL in 1 BOTTLE, UNIT-DOSE (65785-168-01)",
"package_ndc": "65785-168-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20150901"
},
{
"sample": false,
"description": "946 mL in 1 BOTTLE, UNIT-DOSE (65785-168-02)",
"package_ndc": "65785-168-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20150901"
}
],
"productId": "65785-168_445cc5f0-08a7-cb39-e063-6394a90abc68",
"useDomain": "unknown",
"dosageForm": "SOLUTION",
"productNdc": "65785-168",
"deaSchedule": null,
"genericName": "Eyewash",
"productType": "HUMAN OTC DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "WATER",
"strength": "465 mL/473mL"
}
],
"applicationNumber": "NDA022305",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20150130",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "non-prescription",
"harmonizedIdentifiers": {
"unii": [
"059QF0KO0R"
],
"rxcui": [
"1151101",
"1424605"
],
"spl_set_id": [
"0d43b1c1-2699-37f1-e054-00144ff88e88"
],
"manufacturer_name": [
"Niagara Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:65785-168_445cc5f0-08a7-cb39-e063-6394a90abc68"